Posts by Luke

New U.S. Ebola screening rules and unrest around a DRC treatment center show that outbreak response depends as much on public trust and execution capacity as on official restrictions.

The Trump administration’s use of AI to hunt healthcare fraud may expose waste, but it also raises the cost of bad data and opaque enforcement.

The FDA’s June review of Moderna’s mRNA flu vaccine is a public-trust test for a regulator caught between evidence, politics and pandemic-era suspicion.

Sen. Dick Durbin urged RFK Jr. to resist easing flavored-vape rules after FDA moves raised new questions about lobbying, youth nicotine risk, and public-health standards.

Philadelphia health officials are notifying dental patients to seek testing after a license suspension over unsafe conditions at Smiles at Rittenhouse Square.

New federal quarantine orders for American cruise passengers exposed to hantavirus show how fast public-health credibility can become the scarce resource.

A breach affecting at least 1.8 million people at the nation’s largest public health system shows healthcare data risk is now a public-trust issue.

The Ebola headlines are frightening, but the deeper issue is whether public-health institutions still have the trust and capacity to execute under pressure.

CBS News’ investigation of a residential youth treatment center points to a larger failure of oversight, incentives and public trust.

Campaigners are threatening legal action over a UK-US drug-pricing deal they say lets ministers override NICE, exposing how trade politics can creep into health-care cost decisions.